June 9, 2020 / 11:39 AM / 25 days ago

BRIEF-Can-Fite To Advance Piclidenoson Into Phase II Covid-19 Trial In The U.S.

June 9 (Reuters) - Can Fite Biopharma Ltd:

* FOLLOWING PRE-IND GUIDANCE FROM FDA CAN-FITE TO ADVANCE PICLIDENOSON INTO PHASE II COVID-19 TRIAL IN THE U.S.

* CAN FITE BIOPHARMA LTD - IND & PHASE II PROTOCOL EXPECTED TO BE FILED BY END OF JUNE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below